Zhongzhu Historical Income Statement

600568 Stock

1.57 0.01 0.64%

Historical analysis of Zhongzhu Medical income statement accounts such as Selling General Administrative of 86.5 M, Total Revenue of 901.1 M or Cost Of Revenue of 712.1 M can show how well Zhongzhu Medical Holdings performed in making a profits. Evaluating Zhongzhu Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Zhongzhu Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Zhongzhu Medical Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Zhongzhu Medical Holdings is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhongzhu Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Zhongzhu Income Statement Analysis

Zhongzhu Medical Holdings Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Zhongzhu Medical shareholders. The income statement also shows Zhongzhu investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Zhongzhu Medical Income Statement Chart

At present, Zhongzhu Medical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 86.5 M, whereas Operating Income is projected to grow to (111.8 M).

Selling General Administrative Total Revenue Income Tax Expense Research Development

Total Revenue

Total revenue comprises all receipts Zhongzhu Medical Holdings generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most accounts from Zhongzhu Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Zhongzhu Medical Holdings current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhongzhu Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Gross Profit	166.2M	127.5M	161.1M	178.5M
Research Development	24.7M	18.2M	16.2M	27.2M

Gross Profit Research Development

Zhongzhu Medical income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Research Development	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		0.07	-0.61	0.17	-0.5	-0.49	-0.44	0.0	0.82	-0.43	-0.1	-0.5	-0.81	-0.39	-0.85	-0.84	0.51	0.23	-0.57	0.19
Total Revenue	0.07		0.46	0.93	0.29	0.27	0.54	0.39	-0.01	0.51	-0.03	0.27	0.36	-0.01	0.21	0.2	0.01	0.0	0.17	-0.1
Operating Income	-0.61	0.46		0.21	0.53	0.5	0.91	0.47	-0.37	0.88	-0.45	0.49	0.83	0.21	0.73	0.84	-0.17	0.07	0.57	-0.44
Cost Of Revenue	0.17	0.93	0.21		0.23	0.22	0.25	0.43	-0.02	0.18	0.09	0.22	0.18	0.09	0.15	0.11	-0.14	-0.18	0.13	-0.08
Income Before Tax	-0.5	0.29	0.53	0.23		1.0	0.38	0.14	-0.69	0.46	-0.05	1.0	0.63	0.53	0.66	0.62	-0.6	-0.65	0.93	0.1
Net Income	-0.49	0.27	0.5	0.22	1.0		0.34	0.13	-0.69	0.42	-0.03	1.0	0.61	0.54	0.65	0.6	-0.62	-0.67	0.93	0.11
Income Tax Expense	-0.44	0.54	0.91	0.25	0.38	0.34		0.33	-0.21	0.91	-0.48	0.34	0.79	0.01	0.48	0.63	0.04	0.23	0.41	-0.24
Minority Interest	0.0	0.39	0.47	0.43	0.14	0.13	0.33		0.06	0.18	-0.58	0.12	0.23	0.47	0.42	0.48	-0.28	-0.15	0.31	-0.7
Research Development	0.82	-0.01	-0.37	-0.02	-0.69	-0.69	-0.21	0.06		-0.19	-0.3	-0.69	-0.69	-0.46	-0.72	-0.68	0.6	0.46	-0.69	-0.15
Gross Profit	-0.43	0.51	0.88	0.18	0.46	0.42	0.91	0.18	-0.19		-0.28	0.42	0.74	-0.01	0.48	0.54	0.07	0.2	0.39	-0.22
Other Operating Expenses	-0.1	-0.03	-0.45	0.09	-0.05	-0.03	-0.48	-0.58	-0.3	-0.28		-0.03	-0.13	-0.07	-0.09	-0.31	-0.06	-0.13	-0.27	0.36
Net Income From Continuing Ops	-0.5	0.27	0.49	0.22	1.0	1.0	0.34	0.12	-0.69	0.42	-0.03		0.6	0.55	0.65	0.6	-0.62	-0.68	0.93	0.11
Ebit	-0.81	0.36	0.83	0.18	0.63	0.61	0.79	0.23	-0.69	0.74	-0.13	0.6		0.37	0.8	0.85	-0.42	-0.18	0.64	-0.19
Total Operating Expenses	-0.39	-0.01	0.21	0.09	0.53	0.54	0.01	0.47	-0.46	-0.01	-0.07	0.55	0.37		0.67	0.55	-0.86	-0.79	0.65	-0.41
Total Other Income Expense Net	-0.85	0.21	0.73	0.15	0.66	0.65	0.48	0.42	-0.72	0.48	-0.09	0.65	0.8	0.67		0.95	-0.73	-0.48	0.75	-0.43
Tax Provision	-0.84	0.2	0.84	0.11	0.62	0.6	0.63	0.48	-0.68	0.54	-0.31	0.6	0.85	0.55	0.95		-0.59	-0.31	0.75	-0.44
Net Interest Income	0.51	0.01	-0.17	-0.14	-0.6	-0.62	0.04	-0.28	0.6	0.07	-0.06	-0.62	-0.42	-0.86	-0.73	-0.59		0.91	-0.71	0.13
Interest Income	0.23	0.0	0.07	-0.18	-0.65	-0.67	0.23	-0.15	0.46	0.2	-0.13	-0.68	-0.18	-0.79	-0.48	-0.31	0.91		-0.67	-0.06
Ebitda	-0.57	0.17	0.57	0.13	0.93	0.93	0.41	0.31	-0.69	0.39	-0.27	0.93	0.64	0.65	0.75	0.75	-0.71	-0.67		0.0
Reconciled Depreciation	0.19	-0.1	-0.44	-0.08	0.1	0.11	-0.24	-0.7	-0.15	-0.22	0.36	0.11	-0.19	-0.41	-0.43	-0.44	0.13	-0.06	0.0

Click cells to compare fundamentals

Zhongzhu Medical Account Relationship Matchups

Zhongzhu Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	8.1M	5.0M	15.9M	15.0M	7.5M	7.8M
Selling General Administrative	137.0M	99.4M	91.2M	84.5M	86.2M	86.5M
Total Revenue	696.2M	727.5M	581.1M	506.0M	638.6M	901.1M
Operating Income	(101.9M)	(23.6M)	(51.4M)	(190.1M)	(117.7M)	(111.8M)
Cost Of Revenue	529.9M	550.2M	414.8M	378.5M	477.5M	712.1M
Income Before Tax	(375.2M)	42.5M	(187.4M)	(801.3M)	(338.4M)	(321.5M)
Net Income Applicable To Common Shares	(369.5M)	3.2M	(211.3M)	(799.2M)	(719.3M)	(683.3M)
Net Income	(368.0M)	3.2M	(211.3M)	(799.2M)	(343.9M)	(326.7M)
Income Tax Expense	(12.3M)	27.9M	21.1M	(9.6M)	(11.1M)	(10.5M)
Minority Interest	206.2M	183.8M	(2.8M)	(7.5M)	(5.5M)	(5.2M)
Research Development	61.3M	23.4M	24.7M	18.2M	16.2M	27.2M
Gross Profit	166.3M	177.3M	166.2M	127.5M	161.1M	178.5M
Other Operating Expenses	5.6M	6.2M	10.1M	109.5M	126.0M	132.3M
Net Income From Continuing Ops	(362.7M)	14.6M	(208.5M)	(791.7M)	(338.4M)	(355.3M)
Ebit	(514.2M)	(32.4M)	(108.0M)	(211.7M)	(190.5M)	(181.0M)
Total Operating Expenses	799.9M	751.1M	632.5M	696.0M	756.3M	589.1M
Tax Provision	(12.5M)	27.9M	21.1M	(9.6M)	15.9K	15.1K
Net Interest Income	1.5M	14.4M	3.8M	9.0M	17.7M	12.1M
Interest Income	10.1M	19.7M	20.1M	24.4M	25.4M	20.1M
Ebitda	(296.9M)	129.9M	(69.9M)	(686.7M)	(789.8M)	(829.2M)
Reconciled Depreciation	71.6M	82.5M	101.7M	99.6M	79.6M	89.3M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Zhongzhu Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Zhongzhu Historical Income Statement

About Zhongzhu Income Statement Analysis

Zhongzhu Medical Income Statement Chart

Total Revenue

Zhongzhu Medical income statement Correlations

Zhongzhu Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Zhongzhu Medical income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Zhongzhu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 1.0	Income Before Tax
Net Income From Continuing Ops	+ 1.0	Income Before Tax
Net Income From Continuing Ops	+ 1.0	Net Income
Tax Provision	+ 0.95	Total Other Income Expense Net
Cost Of Revenue	+ 0.93	Total Revenue
Ebitda	+ 0.93	Income Before Tax

Net Interest Income	- 0.86	Total Operating Expenses
Total Other Income Expense Net	- 0.85	Selling General Administrative
Tax Provision	- 0.84	Selling General Administrative
Ebit	- 0.81	Selling General Administrative
Interest Income	- 0.79	Total Operating Expenses
Net Interest Income	- 0.73	Total Other Income Expense Net